Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants
A series of potent HCV NS3·4A protease inhibitors incorporating novel 3-substituted proline moieties at the P2 position are described.
References (15)
- et al.
Bioorg. Med. Chem.
(2003)et al.Bioorg. Med. Chem. Lett.
(2002) Science
(1994)- Perni, R.; Court, J.; O'Malley, E.; Rao, B. G., PCT WO 01/74768...
- et al.
Tetrahedron: Asymmetry
(1992) - et al.
Tetrahedron
(1996) - et al.
J. Org. Chem.
(1986) - et al.
Exp. Opin. Invest. Drugs
(2003)For a comprehensive recent review see: Perni, R. B.; Kwong, A. D. In Progress in Medicinal Chemistry; King F. D.,...
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2004 Elsevier Ltd. All rights reserved.